Published
The Drugs Controller General of India (DCGI) has accorded permission to conduct the Phase II-III clinical trial of Covaxin (Covid vaccine) in the age group of two to 18-years-old to its manufacturer Bharat Biotech Ltd, Union Health Ministry said on Thursday.
"The trial will be conducted in 525 healthy volunteers," said the Ministry.
In the trial, the Ministry said, the vaccine will be given by intramuscular route in two doses at day 0 and day 28.
In a latest update on the vaccination front, the gap between two doses of the Covishield Covid-19 vaccine can be increased to 12-16 weeks, as per the government panel suggestions.
"The trial will be conducted in 525 healthy volunteers," said the Ministry.
In the trial, the Ministry said, the vaccine will be given by intramuscular route in two doses at day 0 and day 28.
In a latest update on the vaccination front, the gap between two doses of the Covishield Covid-19 vaccine can be increased to 12-16 weeks, as per the government panel suggestions.
- Category
- Asia
- Tags
- 2 to 18-years-old, Covaxin, Dcgi
Sign in or sign up to post comments.
Be the first to comment
Up Next
Autoplay
-
03:14
Clinical trial of Covaxin's 3rd dose to start soon, Dr Sanjay Roy explains the need
-
02:33
Lab-grown blood given to people in world-first clinical trial - BBC News
-
02:43
DNA: 2-18 वर्ष के बच्चों के लिए Covaxin Clinical Trials को DGCI की मंजूरी | Coronavirus Vaccine
-
02:17
Covid-19 Vaccine: Covaxin Phase 3 Trial Data Shared With Expert Panel Which Meets Today
-
03:04
Coronavirus Vaccine | Covaxin Recommended For Next Phase Of Trials For 2-18 Age Group: Report
-
09:11
Covaxin Phase 1 Trial Clears Lancet Review, Phase 3 Trial Ongoing
-
15:17
Clinical Trials Of Covaxin Are Based On 2 Doses, Haryana HM Took Only 1: Bharat Biotech | ABP News
-
01:50
Covid-19 Pandemic: FDA approves first herbal medicine for clinical trial for treatment (2-2-21)
-
03:25
Covaxin Can Be Taken Off "Clinical Trial Mode", Expert Panel Recommends
-
01:17
2-6 वर्ष के बच्चों के लिए Covaxin Coronavirus Vaccine का Clinical Trial शुरू |COVID-19 Breaking News
-
02:55
Covaxin 77.8% Effective In Phase 3 Trial Data: Sources
-
02:59
Covaxin Phase 3 Data Shows 77.8% Efficacy, Says Lancet
-
18:21
Corona Vaccine पर 'डबल खुशखबरी', Covishield और Covaxin को DCGI की ने दी मंजूरी | Breaking News
-
05:46
AMU Vice-Chancellor Registers Himself As First Volunteer Of Covaxin Phase-3 Trial
-
03:29
Taking part in a clinical vaccine trial as a nine-year-old - BBC News
-
22:11
Corona Crisis: DCGI approves phase II & III trial of Covaxin for kids
-
10:26
Covid-19 Vaccine: Bharat Biotech Releases Covaxin's Phase 3 Trial Data, Claims 77.8% Efficacy
-
09:36
Bhopal: Volunteer dies during 3rd phase Covaxin trial, Bharat Biotech issues clarification
-
17:09
Third phase trial results of Covaxin to release soon | Master Stroke
-
02:42
Covaxin Shows Interim Efficacy Of 81% In Phase 3 Results: Bharat Biotech
-
02:23
Bharat Biotech Enrols Over 25,000 Volunteers For Covaxin Phase 3 Trial
-
17:09
Third phase trial results of Covaxin to release soon | Master Stroke
Loading...